Docket Number:11A-1030623
Inventor: Shui-Tein Chen, Chong-Jen Yu, Laddawan Potprommanee, Haou-Tzong Ma
IP Status:US 10048264 B2、TW pending
Abstract:
Effective biomarkers for early diagnosis of lung cancer are needed. A recent study demonstrated that urinary GM2-activator protein (GM2AP) level was increased in lung cancer patients. This study aims to validate the potential application of GM2AP as a biomarker for diagnosis of lung cancer.
Fields of Application:
diagnosis of lung cancer
Advantages when compared to the existing technologies:
higher sensitivity and specificity
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
